News Australia re-classifies MDMA and psilocybin to be prescribed as medicine Psychiatrists can now prescribe MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression Natalia Buendia CalvilloFebruary 3, 2023
Industry update Australia to spend $14.5M on psychedelic drug trials Australia is funding research to see if magic mushrooms and ecstasy can treat depression and PTSD Jared GnamMarch 17, 2021
Data Only 3% of Australians using medical weed get it from licit market: study Complaints of inadequate regulatory framework and prohibitive cost mirror criticisms in Canada Michelle GamageJune 17, 2020